Xvivo Perfusion AB (publ) (XVIPF)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	638	638	1,392	1,032	524	909
Market Cap Growth	-48.06%	-54.18%	34.85%	97.06%	-42.36%	-17.26%
Enterprise Value	619	621	1,353	976	494	878
Last Close Price	23.52	20.70	41.10	22.80	20.55	30.97
PE Ratio	233.74	233.59	89.46	113.04	296.26	1007.78
PS Ratio	7.24	7.24	18.73	17.37	13.15	31.80
PB Ratio	2.78	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.02	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	58.20	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	6.78	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	39.78	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	62.33	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.43%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.